Michael Drazer to Protein Kinase Inhibitors
This is a "connection" page, showing publications Michael Drazer has written about Protein Kinase Inhibitors.
Connection Strength
0.214
-
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors. Haematologica. 2023 08 01; 108(8):2234-2239.
Score: 0.170
-
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 02; 22(1):43-69.
Score: 0.044